Parkinsons Articles

Dosing begins in phase 1 safety study of new LRRK2 inhibitor

Dosing has begun in a Phase 1 clinical trial of healthy volunteers to evaluate the safety and pharmacological properties of NEU-723, Neuron23’s oral investigational treatment for Parkinson’s disease. The small molecule candidate therapy is designed to

Parkinsons News Today

Toxic protein levels higher with REM sleep disorder than Parkinson’s

People with REM sleep behavior disorder (RBD), a sleep disturbance that can precede Parkinson’s disease, have higher levels of toxic alpha-synuclein protein clumps in their stool than do Parkinson’s patients and healthy people, a study showed.

Parkinsons News Today

A seasoned caregiver’s top tips for living well with Parkinson’s

I recently began attending a support group for Parkinson’s disease caregivers. Although I may have been one of the group’s youngest members, I’ve been a caregiver for longer than most, as my husband, Arman, was

Parkinsons News Today

Microglia may protect neurons in brain during Parkinson’s early stages

Microglia — the brain’s primary immune cells — can help to keep motor symptoms of Parkinson’s disease from quickly advancing in early disease stages, work in a mouse disease model suggests. Its findings support studies

Parkinsons News Today